Glycated hemoglobin is a form of hemoglobin that is measured primarily to identify the three-month average plasma glucose concentration. The test is limited to a three-month average because the lifespan of a red blood cell is four months (120 days). However, since red blood cells do not all undergo lysis at the same time, HbA1C is taken as a limited measure of three months. It is formed in a non-enzymatic glycation pathway by hemoglobin's exposure to plasma glucose.
High prevalence rate coupled with increasing incidence of diabetes among individuals in developed and developing economies are major factors driving growth of the global glycated hemoglobin testing market. In addition, growing awareness among diabetics for early diagnosis of diabetes so as to help in treatment & management of diabetes is another factor fueling growth of the global glycated hemoglobin testing market.
A major and rising trend in the global glycated hemoglobin testing market is increasing adoption of point-of-care testing for glycated hemoglobin testing by individuals across developed and in some developing economies. Access to results in substantially less amount of time as compared to that of lab based tests is a major factor for this increasing adoption.
The Americas will be the major revenue contributor to the hemoglobin A1C test throughout the forecast period. FActors such as the rising prevalence of diabetes and similar diseases, will fuel the steady growth of the market in this region.
In 2018, the global Glycated Hemoglobin Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Glycated Hemoglobin Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glycated Hemoglobin Testing development in United States, Europe and China.
The key players covered in this study
Abbott
Bio-Rad Laboratories
Danaher
EKF Diagnostics
F. Hoffmann-La Roche
...
Market segment by Type, the product can be split into
Lab Based Test
Point-of-Care Test
Market segment by Application, split into
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Glycated Hemoglobin Testing status, future forecast, growth opportunity, key market and key players.
To present the Glycated Hemoglobin Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Glycated Hemoglobin Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Summary:
Get latest Market Research Reports on Glycated Hemoglobin Testing . Industry analysis & Market Report on Glycated Hemoglobin Testing is a syndicated market report, published as Global Glycated Hemoglobin Testing Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Glycated Hemoglobin Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.